Boitano Teresa K L, Powell Mary A, Leath Charles A, Michael Straughn J, Scarinci Isabel C
Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.
University of Alabama at Birmingham, School of Public Health, Birmingham, AL, United States.
Gynecol Oncol Rep. 2022 Feb 28;40:100950. doi: 10.1016/j.gore.2022.100950. eCollection 2022 Apr.
This study was performed to evaluate the barriers and facilitators associated with patient presentation for early stage (ES) versus advanced stage (AS) cervical cancer (CC).
A mixed-method approach was used to collect quantitative (i.e., demographics and medical/screening histories) and qualitative data (individual interviews assessing patients' perceptions regarding their general health, HPV and CC screening, and barriers and facilitators to CC care). Two separate investigators coded the interviews for major themes that occurred with an agreement that 50% or more of the themes would be included.
Twenty-five women agreed to participate in the study with 80% completing the interview. Patients with ES disease were classified as Stage IA1-Stage IB3; patients with Stage IIA-IVB disease were classified with AS disease. Frequent barriers in the ES group were lack of knowledge, competing priorities, feeling healthy, lack of time or health insurance, and being embarrassed/uncomfortable. Frequent barriers in the AS group were lack of knowledge, competing priorities, avoidance/procrastination, fear of the healthcare system or finding something wrong, and lack of perceived risk to CC. Facilitators for ES included understanding the importance of the Pap test, having an abnormal Pap test, and knowing someone with CC. Having abnormal symptoms was the only facilitator for AS patients.
Structural and intrapersonal barriers to CC care persist but differ between ES and AS patients. Multi-level interventions are needed to address the wide array of issues that women highlighted in this study including potential innovative methods to increase access to care and engagement with the healthcare system.
本研究旨在评估早期(ES)与晚期(AS)宫颈癌(CC)患者就诊的障碍因素与促进因素。
采用混合方法收集定量数据(即人口统计学信息和医疗/筛查史)和定性数据(通过个体访谈评估患者对自身总体健康状况、HPV和CC筛查以及CC治疗的障碍因素与促进因素的看法)。两名独立研究人员对访谈内容进行编码,确定出现频率达到或超过50%的主要主题。
25名女性同意参与研究,其中80%完成了访谈。ES期疾病患者被分类为IA1期至IB3期;IIA期至IVB期疾病患者被分类为AS期疾病。ES组常见的障碍因素包括知识缺乏、事务繁多、感觉健康、缺乏时间或医疗保险以及感到尴尬/不自在。AS组常见的障碍因素包括知识缺乏、事务繁多、回避/拖延、害怕医疗系统或查出问题以及未意识到CC的风险。ES组的促进因素包括理解巴氏试验的重要性、巴氏试验结果异常以及认识CC患者。出现异常症状是AS组患者唯一的促进因素。
CC治疗的结构和个人障碍依然存在,但ES组和AS组患者存在差异。需要采取多层次干预措施来解决女性在本研究中强调的一系列问题,包括增加医疗服务可及性和提高与医疗系统互动的潜在创新方法。